Literature DB >> 13647591

Ataractic and anti-emetic drugs in cataract surgery.

R D HARLEY, J E MISHLER.   

Abstract

Entities:  

Keywords:  CATARACT EXTRACTION/anesthesia and analgesia; CHLORPROMAZINE/therapeutic use; EYELIDS/diseases; PHENOTHIAZINE/related compounds

Mesh:

Substances:

Year:  1958        PMID: 13647591      PMCID: PMC1316236     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  11 in total

1.  Sedation for ophthalmic surgery: combination of chlorpromazine, promezathine, and pethidine.

Authors:  R A BURN; D A HOPKIN; G EDWARDS; C M JONES
Journal:  Br J Ophthalmol       Date:  1955-06       Impact factor: 4.638

2.  Chlorpromazine hydrochloride in intraocular surgery.

Authors:  A B NUTT; H L WILSON
Journal:  Br Med J       Date:  1955-06-18

3.  A comparison of some phenothiazine derivatives in inhibiting apomorphine-induced emesis.

Authors:  H ROSENKILDE; W M GOVIER
Journal:  J Pharmacol Exp Ther       Date:  1957-07       Impact factor: 4.030

4.  Some aspects of geriatric ophthalmology.

Authors:  J H KING
Journal:  Eye Ear Nose Throat Mon       Date:  1957-11

5.  Antiemetic properties of a new chlorphenothiazine derivative, proclorperazine.

Authors:  D G FRIEND; G A MCLEMORE
Journal:  AMA Arch Intern Med       Date:  1957-05

6.  The use of chlorpromazine in cataract surgery; a preliminary report.

Authors:  R D HARLEY; J E MISHLER
Journal:  Am J Ophthalmol       Date:  1957-05       Impact factor: 5.258

7.  The treatment of anxiety, agitation and excitement in the aged; a preliminary report on trilafon.

Authors:  F J AYD
Journal:  J Am Geriatr Soc       Date:  1957-01       Impact factor: 5.562

8.  Thorazine as preoperative medication in ophthalmology and otolaryngology.

Authors:  M H FRITZ
Journal:  Eye Ear Nose Throat Mon       Date:  1955-08

9.  Emesis and hiccough; treatment with chlorpromazine.

Authors:  B L STEWART; A G REDEKER
Journal:  Calif Med       Date:  1954-09

10.  Chlorpromazine (largactil) as a premedication in ophthalmic surgery.

Authors:  J G MOORE
Journal:  Br J Ophthalmol       Date:  1955-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.